A subset of HLA-B27 molecules contains peptides much longer than nonamers.
about
Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptidesPeptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approachHuman transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cellsHLA-B27 subtypes differentially associated with disease exhibit subtle structural alterationsFrom HLA-B27 to spondyloarthritis: a journey through the ER.Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseAntigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cellsEnhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.Minimal alterations in the HLA-B27-bound peptide repertoire induced upon infection of lymphoid cells with Salmonella typhimurium.Peptide length preferences for rat and mouse MHC class I molecules using random peptide libraries.Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells.ERAP1 reduces accumulation of aberrant and disulfide-linked forms of HLA-B27 on the cell surfaceCytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat.Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401.Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.Kinetics of antigen expression and epitope presentation during virus infection.HLA-B27: natural function and pathogenic role in spondyloarthritis.Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system.Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation.Use of proteomics to define targets of T-cell immunity.Trimming of antigenic peptides in an early secretory compartment.The peptide-binding motif for the human transporter associated with antigen processingCytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing.HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m.A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells.HLA-B27 Anterior Uveitis: Immunology and Immunopathology.Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.Alteration of HLA-B27 peptide presentation after infection of transfected murine L cells by Shigella flexneri.T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance.HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum.Presentation without proteolytic cleavage of endogenous precursors in the MHC class I antigen processing pathway.Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.Hypothesis: MHC class I, rather than just a flagpole for CD8+ T cells is also a protease in its own right.Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling.Characterization of a proteasome and TAP-independent presentation of intracellular epitopes by HLA-B27 molecules
P2860
Q24651238-736AA8E3-8043-41F2-A366-4E73CC7D7CFCQ24800285-F9AB9C86-785E-4F43-80D6-F3AEFBDB1654Q27485141-BE9ADE89-251C-45F6-AAED-AFDBF816FA35Q27639674-E694342D-1525-46D7-B462-727403979906Q27687662-C69D52C9-8107-4335-9822-1E310C13B676Q28238379-3A28D222-B16D-4106-B7B9-3EB230E16AF7Q28348352-4C4A7C41-88C8-4387-B2FC-9A7E790295D4Q30479692-28890E01-D148-4521-988C-B935FFB699D8Q30996254-2CDCC19D-E223-4B0C-AE2C-F3A09E643789Q32065988-60973706-EE11-4563-8D62-090892305851Q33179056-B49BBD06-0DA3-466F-BEFC-4F538571BEC6Q33660017-84B479F8-2F17-48AB-B6D3-A635E1389029Q34001315-8D822D42-817E-4274-A2F3-5156A6472EC4Q34416556-F21E63C7-9CBE-42E8-BDE9-9E2907C98E85Q34499385-3371C472-188D-47F8-AF16-2ACEF75E6A89Q34574829-42CB614F-B61E-4FEC-87F7-B4B6F6A9082FQ34731174-02FD1A55-5B69-46F3-88CA-C23D8BEC53FCQ35157414-31C0F5EF-83D1-4E30-93B9-7ACCCC93C647Q35857485-1A6B3EEC-9A87-4B92-B1A4-B3F368187922Q35928276-9554996B-61C8-4221-AC2B-3B82285E600BQ36184807-00104417-EE4D-4442-BCD2-7C8FEA032211Q36364157-B0883B02-F132-4524-B032-4B68B55CE452Q36365611-0CE8B719-0B11-455D-9EF6-0E2BE373D0F1Q36375737-A29FB94E-B956-4C1E-826D-AD16FC15EB41Q36380657-E8764293-82D6-4DCD-AE07-8AA7B9358D49Q37362131-9227B4E9-9B2F-46D7-B662-3B072C53481EQ37886022-67476E61-78C0-484A-BFFC-37D071F7DE4FQ38380973-FC6B2374-32CB-40FB-8B70-40870F094322Q38437145-25B43628-0788-40B3-80FB-EDECBD396DCCQ38849274-9CD584E8-83C7-4BC1-8F43-96C253A841CFQ39214326-AD8A6ABE-584E-4C12-B993-61346C8D9C02Q39572956-B935DC6E-DCDB-474E-9C83-53F96C8F5EE1Q40368484-5BE873BF-D53D-4B1F-84CF-C2F952080D76Q40431345-B90B0D18-6F7C-4DAF-8764-89582D24B364Q40735553-7217B035-F349-4D53-B496-A2A03D6339F6Q41358678-E8388CBB-4D0C-4F8E-B471-B9F827EDEC5EQ41373011-36F74CF4-1316-45C6-9A97-6F5E4368CC87Q41550870-59A7E3F2-F24D-4C4E-90E9-113648107216Q41819018-C4882D7D-0C85-4D7D-891D-91356470BBDCQ42037645-760D2B87-7528-4C60-85D4-0C46C8BD1A6B
P2860
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@ast
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@en
type
label
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@ast
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@en
prefLabel
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@ast
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@en
P2093
P2860
P356
P1476
A subset of HLA-B27 molecules contains peptides much longer than nonamers.
@en
P2093
B Uchanska-Ziegler
F G UytdeHaag
M J Kenter
P2860
P304
P356
10.1073/PNAS.91.4.1534
P407
P577
1994-02-01T00:00:00Z